Alveron Pharma raised €5M in a Seed extension financing led by Broadview Ventures to accelerate the development of its drug OKL-1111 for intracranial haemorrhage.
Amount Raised
€5 Million
Round Type
Seed
NijmegenBiotechnologyHealth CareTherapeuticsInvestors
Description
Alveron Pharma closed a €5 million Seed extension financing to advance its innovative drug OKL-1111, aimed at treating intracranial haemorrhage. The round was led by Broadview Ventures with participation from existing investors. This funding will help accelerate development activities for further clinical studies.
Quick answer
Alveron Pharma raised €5 Million in a Seed round, dated December 6, 2024. Investors: Oost NL, Sanquin, Thuja Capital, Waterman Ventures and Broadview Ventures. Alveron Pharma is based in Nijmegen, Gelderland, Netherlands.
- How much did Alveron Pharma raise?
- Alveron Pharma raised €5 Million in a Seed round on December 6, 2024.
- Who invested in Alveron Pharma?
- Oost NL, Sanquin, Thuja Capital, Waterman Ventures and Broadview Ventures are named as investors in this round.
- What does Alveron Pharma do?
- Alveron Pharma is developing a unique coagulation platform technology with the world's first cyclodextrin-based anticoagulant reversal drug
- Where is Alveron Pharma based and how big is it?
- Alveron Pharma is based in Nijmegen, Gelderland, Netherlands.
- Who are the decision-makers at Alveron Pharma?
- Fundz holds 1 contact at Alveron Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Alveron Pharma that raised within 45 days of this round, from Fundz verified event records.
- Phio Pharmaceuticals raised $153K (Seed) on January 17, 2025.
- VisiRose raised $3M (Seed) on January 16, 2025.
- Phio Pharmaceuticals raised $208K (Seed) on January 15, 2025.
- Phio Pharmaceuticals raised $266K (Seed) on January 14, 2025.
- First Ascent Biomedical raised $6M (Angel) on January 13, 2025.
- Neumirna Therapeutics raised $20M (Series A) on January 13, 2025.
Who to call at Alveron Pharma, and when
A new round usually means Alveron Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alveron Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alveron Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alveron Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alveron Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alveron Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.